Interferon beta-associated retinopathy in patients treated for multiple sclerosis.
Folden
David V
DV
Departments of Ophthalmology, University of Minnesota, Minneapolis, USA.
Lee
Michael S
MS
Ryan
Edwin H
EH
D005260:Female; D005654:Fundus Oculi; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects; D016899:Interferon-beta / Q000009:adverse effects*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D012160:Retina / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D012162:Retinal Degeneration / Q000139:chemically induced* / Q000276:immunology / Q000503:physiopathology; D015354:Vision, Low / Q000139:chemically induced / Q000276:immunology / Q000503:physiopathology; D028761:Withholding Treatment
D007155:Immunologic Factors; D016899:Interferon-beta